Profound Medical (PROF) Free Cash Flow (2024 - 2026)

Profound Medical's Free Cash Flow history runs 3 years deep, the most recent figure standing at -$8.6 million for Q1 2026.

• On a quarterly basis, Free Cash Flow fell 3.62% year-over-year to -$8.6 million in Q1 2026; TTM through Mar 2026 was -$38.5 million, a 41.53% decrease from a year earlier, with the FY2025 full-year figure at -$38.4 million, down 63.66% from the prior year.
• Free Cash Flow declined to -$8.6 million in Q1 2026 per PROF's latest filing, from -$6.6 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$4.5 million in Q1 2024 and bottomed at -$13.7 million in Q2 2025.
• The 3-year median for Free Cash Flow is -$6.8 million (2024), against an average of -$7.8 million.
• Across the five-year window, Free Cash Flow slumped 121.0% in 2025 and decreased 3.62% in 2026, its largest moves.
• Year by year, Free Cash Flow stood at -$5.9 million in 2024, then declined by 11.69% to -$6.6 million in 2025, then sank by 30.72% to -$8.6 million in 2026.
• Per Business Quant, the three latest PROF Free Cash Flow figures stand at -$8.6 million (Q1 2026), -$6.6 million (Q4 2025), and -$9.6 million (Q3 2025).